Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

HbA1c and beyond

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Essential Branched-Chain Amino Acids and Ribonic Acid Are Associated with Cardiorenal Events in Type 1 Diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations

The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on Diabetes Management in Chronic Kidney Disease from 2020 comes at an opportune time when progress in diabetes technology and therapeutics offer new options to manage the large population of patients with diabetes and CKD at high risk of poor health outcomes. Management of hemoglobin A1c is important in diabetes but an enlarging base of evidence from large clinical trials have demonstrated important new treatments offering organ protection and not just glucose management, such as sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists. It is the ambition that the guideline can help to optimize the clinical care of people with diabetes and CKD by integrating new options with existing management strategies based on high quality evidence. Here the focus has been on comprehensive care of patients with diabetes and CKD, glycemic monitoring and targets, antihyperglycemic therapies in patients with diabetes and CKD, and new developments since the guideline was published offering new opportunities and a wider target population for the new interventions.

Original languageEnglish
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN0931-0509
DOIs
Publication statusE-pub ahead of print - 12 Aug 2021

Bibliographical note

© The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

ID: 67682963